Cypress Bioscience Inc.’s (CYPB) share price has moved into oversold territory with a stochastic value of 18.95. Analysts have been increasing their estimates on the Zacks #2 Rank (“Buy”) company’s full-year earnings, with the consensus up a penny over the past month to a loss 76 cents per share.
“CYPB” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research